Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping

Journal of Infection in Developing Countries

Volumn 7, Issue 8, 2013, Pages 618-629

  Hassan, Manal I ^a,b   Alkharsah, Khaled R ^b   Alzahrani, Alhusain J ^c   Obeid, Obeid E ^b   Khamis, Amar H ^b   Diab, Asim ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobials; Beta lactamase; Enterobacteriaceae; ESBL; Transconjugation

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFAZOLIN; CEFEPIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISK DIFFUSION; ENZYME SYNTHESIS; FEMALE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; QUALITY CONTROL PROCEDURES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CONJUGATION, GENETIC; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE TRANSFER, HORIZONTAL; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; PREVALENCE; SAUDI ARABIA; YOUNG ADULT;

EID: 84881620970     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2919     Document Type: Article

References (42)

1. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
2. Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14: 933-951.
3. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL (2001) Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39: 2206-2212.
4. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP (2006) Impact of extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27: 1226-1232.
5. Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, Barth AL, Echeverrigaray S, Costa SO (2011) Nosocomial and community infections due to class A extended-spectrum beta-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis 15: 138-143.
6. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11: 315-317.
7. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
8. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N (2007) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165-174.
9. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P (2008) Molecular characterization and epidemiology of extendedspectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52: 2818-2824.
10. Bali EB, Acik L, Sultan N (2010) Phenotypic and molecular characterization of SHV, TEM, CTX-M and extendedspectrum beta lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res 4: 650-654.
11. Clinical Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. 21st informational supplement. CLSI document M100-S18. CLSI: Wayne, PA.
12. Robberts FJL, Kohner PC, Patel R (2009) Unreliable extended-spectrum β-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. J Clin Microbiol 47: 358-361.
13. Kohner PC, Robberts FJL, Cockerill III FR, Patel R (2009) Cephalosporin MIC distribution of extended-spectrum-β-lactamaseand pAmpC-producing Escherichia coli and Klebsiella species. J Clin Microbiol 47: 2419-2425.
14. Bauernfeind A, Chong Y, Schweighart S (1989) Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17: 316-321.
15. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS (2006) Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 44: 3318-3324.
16. Thomson KS (2001) Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7: 333-336.
17. Munier GK, Johnson CL, Snyder JW, Moland ES, Hanson ND, Thomson KS (2010) Positive extended-spectrum-betalactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs. J Clin Microbiol 48: 673-674.
18. Pitout JD, Le PG, Moore KL, Church DL, Gregson DB (2010) Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clin Microbiol Infect 16: 165-170.
19. Al-Agamy MH, Shibl AM, Tawfik AF (2009) Prevalence and molecular characterization of extended-spectrum betalactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 29: 253-257.
20. Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH (2011) Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microb Drug Resist 17: 383-388.
21. Crichton PB (1996) Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera, in Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. London: Churchill Livingstone 361-413.
22. Coudron PE (2005) Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 43: 4163-4167.
23. Thomson KS (2010) Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol 48: 1019-1025.
24. Kader AA, Kumar AK (2004) Prevalence of extended spectrum beta-lactamase among multidrug resistant gramnegative isolates from a general hospital in Saudi Arabia. Saudi Med J 25: 570-574.
25. Khanfar HS, Bindayna KM, Senok AC, Botta GA (2009) Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 3: 295-299.
26. El-Khizzi NA and Bakheshwain SM (2006) Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 27: 37-40.
27. Kader AA and Angamuthu K (2005) Extended-spectrum betalactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J 26: 956-959.
28. Kader AA, and Kumar A (2005) Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 25: 239-242.
29. Kader AA, Kumar A, Dass SM (2004) Antimicrobial resistance patterns of gram-negative bacteria isolated from urine cultures at a general hospital. Saudi J Kidney Dis Transpl 15: 135-139.
30. Babay HA (2002) Detection of extended-spectrum blactamases in members of the family enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J 23: 186-190.
31. Panhotra BR, Saxena AK, Al-Ghamdi AM (2004) Extendedspectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia: Risk factors and clinical outcome. Saudi Med J 25: 1871-1876.
32. Bindayna KM, Senok AC, Jamsheer AE (2009) Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2: 129-135.
33. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO (2008) The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 20: 445-451.
34. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D (2008) Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 17: 32-36.
35. Rudresh SM, Nagarathnamma T (2011) Extended spectrum beta-lactamase producing Enterobacteriaceae & antibiotic coresistance. Indian J Med Res 133: 116-118.
36. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
37. Kader AA, Kumar A, Kamath KA (2007) Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 28: 1114-1116.
38. Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, Woodford N, Livermore DM (2011) Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenemresistant isolates. Antimicrob Agents Chemother 55: 3917-3921.
39. Lartigue MF, Poirel L, Poyart C, Reglier-Poupet H, Nordmann P (2007) Ertapenem resistance of Escherichia coli. Emerg Infect Dis 13: 315-317.
40. Ensor VM, Jamal W, Rotimi VO, Evans JT, Hawkey PM (2009) Predominance of CTX-M-15 extended spectrum betalactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int J Antimicrob Agents 33: 487-489.
41. Tollentino FM, Polotto M, Nogueira ML, Lincopan N, Neves P, Mamizuka EM, Remeli GA, De Almeida MT, Rubio FG, Nogueira MC (2011) High prevalence of bla(CTX-M) extended spectrum beta-lactamase genes in Klebsiella pneumoniae isolates from a tertiary care hospital: first report of bla(SHV-12), bla(SHV-31), bla(SHV-38), and bla(CTX-M-15) in Brazil. Microb Drug Resist 17: 7-16.
42. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN (2007) Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol 45: 1478-1482.